You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
{{ message }}
This repository has been archived by the owner on Jun 21, 2023. It is now read-only.
To assess the affects of tumor purity on our results, we should re-run certain survival models, considering only samples that have tumor_fraction>= median tumor fraction (#1622).
Specifically, we should run the following models and compare results to original results with all tumors:
Model shown in 4F: survival ~ is_lgg + resection + tp53 + extend
I'll note that other modules that were reassessed at a tumor purity threshold were broadly consistent with original results that feed into this module, suggesting (but not meaning for sure!) that results might not be strongly influenced.
Sign up for freeto subscribe to this conversation on GitHub.
Already have an account?
Sign in.
Labels
revisionRelated to manuscript revisionswontfixThis will not be worked on
To assess the affects of tumor purity on our results, we should re-run certain survival models, considering only samples that have
tumor_fraction>= median tumor fraction
(#1622).Specifically, we should run the following models and compare results to original results with all tumors:
survival ~ is_lgg + resection + tp53 + extend
survival~CD274 expr + resection + quantiseq_fraction
The text was updated successfully, but these errors were encountered: